Zhejiang

With 600 Teams Having Participated and Three Major Tracks, This Year's Zhijiang Cup Has Given Birth to a New AI Power

Retrieved on: 
Friday, December 10, 2021

According to statistics, the competition attracted nearly 600 teams with nearly 5,000 participants.

Key Points: 
  • According to statistics, the competition attracted nearly 600 teams with nearly 5,000 participants.
  • ZheJiang Cup has a strict reproduction mechanism, which greatly exercises engineering practice and time planning skills.
  • In the zero-sample target object recognition competition, DH-Goods won with an industrial landing-level solution that is lightweight, high-performance, and easy to deploy.
  • With the conclusion of this year's Zhejiang Cup, Zhejiang Lab has successfully held four global artificial intelligence competitions.

The 2nd "@Beautiful Zhejiang"Global Short Video Contest Discovers the Beauty of Zhejiang through Your Eyes

Retrieved on: 
Monday, December 6, 2021

HANGZHOU, China, Dec. 5, 2021 /PRNewswire/ -- The 2nd "@Beautiful Zhejiang" Global Short Video Contest is sponsored by Information Office of Zhejiang Provincial Government and Zhejiang Radio & TV Group, and organized by Zhejiang international channel (ZTV WORLD) of Zhejiang Radio & TV Group.

Key Points: 
  • HANGZHOU, China, Dec. 5, 2021 /PRNewswire/ -- The 2nd "@Beautiful Zhejiang" Global Short Video Contest is sponsored by Information Office of Zhejiang Provincial Government and Zhejiang Radio & TV Group, and organized by Zhejiang international channel (ZTV WORLD) of Zhejiang Radio & TV Group.
  • Last year, "Beautiful Zhejiang" global short video contest attracted the attention of the world.
  • The 2nd "@Beautiful Zhejiang" Global Short Video Contest is international, open and cooperative, and has attracted wider social attention than the last one since its launch.
  • This contest attracts participants from all walks of life, including individuals and teams, short video experts, universities, media companies and public institutions.

Ebang International to Hold Annual General Meeting of Shareholders on December 15, 2021

Retrieved on: 
Monday, November 15, 2021

HANGZHOU, China, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Ebang International Holdings Inc. (Nasdaq: EBON, the Company ), a blockchain technology company operating in the global market, today announced that it will hold its 2021 Annual General Meeting of Shareholders (the 2021 Annual Meeting) on December 15, 2021 at 9:00 a.m. (Eastern Time), at the offices of Sullivan & Worcester LLP at 1633 Broadway, 32nd Floor, New York, NY 10019.

Key Points: 
  • HANGZHOU, China, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Ebang International Holdings Inc. (Nasdaq: EBON, the Company ), a blockchain technology company operating in the global market, today announced that it will hold its 2021 Annual General Meeting of Shareholders (the 2021 Annual Meeting) on December 15, 2021 at 9:00 a.m. (Eastern Time), at the offices of Sullivan & Worcester LLP at 1633 Broadway, 32nd Floor, New York, NY 10019.
  • The Company filed its annual report on Form 20-F (2020 Annual Report), including its audited financial statements for the fiscal year ended December 31, 2020, with the U.S. Securities and Exchange Commission (the SEC) on April 30, 2021.
  • Shareholders may obtain a copy of the 2020 Annual Report, free of charge, from the Company's investor relations website at https://ir.ebang.com.cn/ , as well as on the SECs website at https://www.sec.gov/ .
  • About Ebang International Holdings Inc.
    Ebang International Holdings Inc. is a blockchain technology company with strong application-specific integrated circuit (ASIC) chip design capability.

Chance Pharmaceuticals Secures $30 Million Series C Funding to Advance Innovative Pipeline and Initiate Additional Business Collaborations

Retrieved on: 
Monday, October 11, 2021

The new funds will be used to advance the companys research and development efforts for its innovative pipeline of inhalation therapies, initiate additional business collaborations, and accelerate the construction of a manufacturing facility.

Key Points: 
  • The new funds will be used to advance the companys research and development efforts for its innovative pipeline of inhalation therapies, initiate additional business collaborations, and accelerate the construction of a manufacturing facility.
  • Chance retains the leading particle engineering knowhow, advanced inhaler design, and proprietary inhalation evaluation platform, with a management team of complementary expertise, commented Mr. Zhihua Yu, Chairman of Lapam Capital.
  • We expect that this funding will accelerate Chances development of their transformative inhalations therapies and benefit more patients.
  • Lapam Capital specializes in investments in start-up, early-stage, and fast-growing companies that have innovative and disruptive pharmaceuticals and medical devices.

Ebang International Holdings Inc. Reports Unaudited Financial Results for The First Six Months of Fiscal Year 2021

Retrieved on: 
Friday, October 1, 2021

Gross profit in the first six months of 2021 was US$5.64 million compared to the gross loss of US$0.97 million in the same period of 2020.

Key Points: 
  • Gross profit in the first six months of 2021 was US$5.64 million compared to the gross loss of US$0.97 million in the same period of 2020.
  • Net loss in the first six months of 2021 was US$4.26 million compared to US$6.96 million in the same period of 2020.
  • Net loss attributable to Ebang International Holdings Inc. in the first six months of 2021 was US$3.58 million compared to US$6.21 million in the same period of 2020.
  • About Ebang International Holdings Inc.
    Ebang International Holdings Inc. is a blockchain technology company with strong application-specific integrated circuit (ASIC) chip design capability.

Hangzhou Chance Pharmaceuticals Appoints Guobao Zhao as Senior Vice President

Retrieved on: 
Thursday, September 30, 2021

HANGZHOU, China, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Hangzhou Chance Pharmaceuticals (Chance), a clinical-stage biotechnology company focusing on discovering, developing, and commercializing transformative inhalation therapies for the worlds most debilitating diseases, today announced that it has appointed Guobao Zhao as Senior Vice President responsible for business development and corporate strategy.

Key Points: 
  • HANGZHOU, China, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Hangzhou Chance Pharmaceuticals (Chance), a clinical-stage biotechnology company focusing on discovering, developing, and commercializing transformative inhalation therapies for the worlds most debilitating diseases, today announced that it has appointed Guobao Zhao as Senior Vice President responsible for business development and corporate strategy.
  • Before joining the Company, Mr. Zhao was Senior Vice President at Delian Capital where he has led Delians investments in Amunix, Apexigen, and MicuRx.
  • In addition, Mr.Zhao also represents Delian as a Board member or observer on OnKure, Hummingbird Bioscience, and Chance Pharmaceuticals.
  • Mr.Zhaocommented, "It has been a tremendous honor to join Chance and serve as Senior Vice President.

Global Concrete Superplasticizers Market (2021 to 2026) - Growth, Trends, COVID-19 Impact and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Monday, September 13, 2021

Among applications, ready-mix concrete dominates the demand for concrete superplasticizers.

Key Points: 
  • Among applications, ready-mix concrete dominates the demand for concrete superplasticizers.
  • Ready-mix concrete is a mixture of various materials, such as Portland cement, fine sand, water, and coarse aggregates.
  • This property leads to the higher mechanical strength of ready-mix concrete compared to normal concrete.
  • Hence, such benefits of ready-mix concrete have been driving its demand, and this, in turn, is increasing the consumption of superplasticizers.

Ebang International Announces Results of Mediation on a Sales Contract Dispute

Retrieved on: 
Tuesday, August 24, 2021

HANGZHOU, China, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Ebang International Holdings Inc. (Nasdaq: EBON, the Company), a blockchain technology company, today announced the results of a mediation related to a dispute from a sales contract with one of its customers.

Key Points: 
  • HANGZHOU, China, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Ebang International Holdings Inc. (Nasdaq: EBON, the Company), a blockchain technology company, today announced the results of a mediation related to a dispute from a sales contract with one of its customers.
  • The rest of 56,000 mining machines will be paid by Niubo in the amount of RMB272 million.
  • All parties confirmed there is no other disputes related to this sales contract.
  • About Ebang International Holdings Inc.
    Ebang International Holdings Inc. is a blockchain technology company with strong application-specific integrated circuit (ASIC) chip design capability.

Yunji to Report Second Quarter 2021 Financial Results on August 26, 2021

Retrieved on: 
Friday, August 20, 2021

Yunji Inc. is a leading social e-commerce platform in China that has pioneered a unique, membership-based model to leverage the power of social interactions.

Key Points: 
  • Yunji Inc. is a leading social e-commerce platform in China that has pioneered a unique, membership-based model to leverage the power of social interactions.
  • The Company's e-commerce platform offers high-quality products at attractive prices across a wide variety of categories catering to the day-to-day needs of Chinese consumers.
  • In addition, the Company uses advanced technologies including big data and artificial intelligence to optimize user experience and incentivize members to promote the platform as well as share products with their social contacts.
  • Through deliberate product curation, centralized merchandise sourcing, and efficient supply chain management, Yunji has established itself as a trustworthy e-commerce platform with high-quality products and exclusive membership benefits, including discounted prices.

Jiuzi Holdings, Inc. Reports First-Half 2021 Financial Results

Retrieved on: 
Thursday, August 5, 2021

For the six months ended April 30, 2021, NEVs sales decreased by $0.28 million or 92.58%, from $0.30 million for the six months ended April 30, 2020 to $0.02 million for the six months ended April 30, 2021.

Key Points: 
  • For the six months ended April 30, 2021, NEVs sales decreased by $0.28 million or 92.58%, from $0.30 million for the six months ended April 30, 2020 to $0.02 million for the six months ended April 30, 2021.
  • As of April 30, 2021, April 30, 2020, the Company has entered into franchise agreements with 86 and 47 franchisees, respectively.
  • On July 19, 2021, the Company announced that it entered into a strategic cooperation agreement with Chongqing Ruichi Automobile Industry Co., Ltd. ("Ruichi") on June 25, 2021.
  • These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy and financial needs.